Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (8574)	2/1/1999 9:03:00 PM
From: Bluegreen	Read Replies (2) \| Respond to of 17367

TEXAS, could you imagine NY Times headline of: XOMA ABOUT TO UNLEASH NEW SUPER-ANTIBIOTIC THAT KILLS EVEN THE MOST "RESISTANT" BACTERIA? My 100 bucks a share opinion might be too conservative. Remember I am saying this after watching ENMD that day it was in the NY TIMES and what happens to some hot internet stocks. These feeding frenzies are happening more often now in this market. Once the MO builds, watch out!

To: Arthur Radley who wrote (8574)	2/1/1999 9:09:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

While I hope he is talking about XOMA, I think he may have some other stock in mind. I would think he might mean Microcide, but they will only start their first phase I trial in Sept., so I would not swer it is them either.